Projected Earnings Date: 2025-02-03    (Delayed quote data   2025-01-06)
Last
 73.77
Change
 ⇑ +0.58   (+0.79%)
Volume
  2,262,619
Open
 73.07
High
 74.49
Low
 73.01
8EMA (Daily)
 72.79
40EMA (Daily)
 75.32
50EMA (Daily)
 75.93
STO (Daily)
 41.436
MACD Hist (Daily)
 0.573
8EMA (Weekly)
 74.714
40EMA (Weekly)
 77.01
50EMA (Weekly)
 76.88
STO (Weekly)
 15.704
MACD Hist (Weekly)
 -1.730
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: breast health (44% of sales), diagnostics (39%) surgical (14%), and skeletal health (3%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (74%), followed by Europe (12%), Asia (9%), and other international markets (5%). Hologic is headquartered in Bedford, Massachusetts.
optionchance optionchance
Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com